Furthermore, we found that CYP39A1 was decreased in the tumor cells of Akt/c-Met-induced HCC mouse model (P < 0.001), however, it was increased in the oral administration of osthole group, especially in the high dose of osthole group. The gene discussed is MET; the disease is hepatocellular carcinoma.